Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2003 | 15.2900763359 | 1.31 | 1.6 | 1.29 | 951513 | 1.47631183 | CS |
| 4 | -0.0097 | -0.638157894737 | 1.52 | 1.6 | 1.1701 | 795721 | 1.39611006 | CS |
| 12 | 0.728798 | 93.2560633242 | 0.781502 | 1.633 | 0.76 | 589274 | 1.28460608 | CS |
| 26 | 0.6854 | 83.0888592557 | 0.8249 | 1.633 | 0.73 | 496292 | 1.10622279 | CS |
| 52 | 0.4003 | 36.0630630631 | 1.11 | 1.633 | 0.6301 | 342462 | 1.03357395 | CS |
| 156 | -1.6997 | -52.9501557632 | 3.21 | 3.64 | 0.6301 | 169317 | 1.30294474 | CS |
| 260 | -11.2397 | -88.1545098039 | 12.75 | 13.5 | 0.6301 | 180784 | 2.3166783 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
